Inhibition of BACE1 and Amyloid-β Aggregation by Meroterpenoids from the Mushroom Albatrellus yasudae.

Journal of Natural Products
Youki MasudaKiyotaka Koyama

Abstract

To develop drugs to treat Alzheimer's disease (AD) on the basis of the amyloid cascade hypothesis, the amyloid-β (Aβ) aggregation inhibitory activities of 110 extracts from mushrooms were evaluated by thioflavin T (Th-T) assays. The MeOH extract of Albatrellus yasudae inhibited Aβ aggregation, and the bioactivity-guided fractionation of the extract afforded four novel meroterpenoids, named scutigeric acid (1), albatrelactone methyl ester (2), albatrelactone (3), and 10',11'-dihydroxygrifolic acid (4), together with two known compounds, grifolin (5) and grifolic acid (6). The structures of 1-4 were elucidated using NMR, MS, UV, IR, and induced ECD spectral data. The structure of 1 was determined as a methyl ester (1a) by 2D NMR spectroscopy. Th-T assays showed that compounds 1-4 and 1a possessed inhibitory activities against Aβ aggregation, with IC50 values of 6.6, 40.7, 51.4, 53.3, and 50.3 μM, respectively. Notably, 1 possessed an inhibitory activity against Aβ aggregation comparable to that of myricetin as a positive control. Moreover, 1-6 exhibited inhibitory activities against BACE1, with IC50 values of 1.6, 10.9, 10.5, 34.4, 6.1, and 1.4 μM, respectively.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Jun 19, 2004·Science·Masaaki MiyashitaKeiji Tanino
Oct 28, 2009·Journal of Natural Products·Fumie IwataHiroyuki Kawahara
Jul 6, 2010·Bioorganic & Medicinal Chemistry Letters·Hiroaki SasakiKunio Takahashi
Jan 20, 2011·Journal of Neurochemistry·Kenjiro Ono, Masahito Yamada
Nov 16, 2011·Chemistry & Biodiversity·Jun-Song WangLing-Yi Kong
Dec 14, 2011·Journal of Natural Products·Miyuki FukaiKiyotaka Koyama
Sep 28, 2013·Journal of Natural Products·Ya-Dan WangShi-Shan Yu
May 27, 2014·Natural Products and Bioprospecting·Liang-Yan LiuJi-Kai Liu
Jan 22, 2015·Acta Neuropathologica·Kirsten L Viola, William L Klein
May 2, 2018·Journal of Natural Products·Hitoshi KamauchiKiyotaka Koyama
Jun 30, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
Jun 28, 2019·Journal of Natural Products·Genki YatsuKiyotaka Koyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.